Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102010376B details an aqueous phase synthesis for quinoxalines using biodegradable ionic liquids, offering high yields and eco-friendly processing for pharmaceutical intermediates.
Patent CN112574225A details a room-temperature gold-catalyzed synthesis of tetrahydrofuran dihydroquinolines, offering high yields and simplified processing for pharmaceutical supply chains.
Patent CN103012319B reveals high-yield DEPBT method for repaglinide intermediates, ensuring supply chain stability and cost reduction.
Novel 3-step route using 2-amino-5-methylbenzoic acid ensures high purity >99% and cost reduction in obesity drug manufacturing.
Novel high-yield synthesis of LND1067 linker for ADCs. Optimized route avoids low-yield intermediates, ensuring cost reduction and supply reliability for pharmaceutical manufacturing.
Patent CN103450073A details a novel rigid chiral catalyst synthesis offering superior stereoselectivity and cost-effective manufacturing for complex pharmaceutical intermediates.
Patent CN110067006A reveals metal-free electrochemical route for antitumor indoles, offering green manufacturing and supply chain advantages for pharma intermediates.
Patent CN103649055B reveals high-yield pyrazole synthesis for DPP-IV inhibitors, offering cost reduction and scalable supply chain solutions for pharma manufacturers.
Patent CN112851674B reveals a novel rhodium-catalyzed double dehydrogenative coupling method for polysubstituted pyrroles, offering high efficiency and functional group diversity for industrial applications.
Patent CN1865234A reveals mild Wittig route for cis-capsaicin. Offers cost reduction and scalable supply for flavor and pharma industries.
Patent CN103333049A reveals a recyclable phosphotungstic acid ionic liquid catalyst for styrene oxide alcoholysis, offering high purity and reduced waste for pharmaceutical intermediate manufacturing.
Novel Cu-Ni catalytic method for high-purity pharmaceutical intermediates. Reduces cost and improves supply chain reliability for global buyers seeking stable production.
Discover the novel one-step preparation and resolution of 2-acylamino-3-biphenylpropionic acid. A cost-effective, high-purity route for API manufacturing.
Novel Ni-catalyzed desulfitative coupling of sulfonyl chlorides offers high yield and broad scope. A cost-effective route for API intermediates and fine chemicals.
Novel Pd-catalyzed C-H activation method ensures 99% ee. Reliable supplier for scalable chiral amine manufacturing with cost efficiency.
Novel catalytic hydrogenation route for Lenalidomide. High purity, reduced solvent use, scalable manufacturing for API intermediates.
Patent CN115403494B enables air-oxidized, metal-free synthesis of beta-hydroxy sulfones. Delivers high purity, cost efficiency, and scalable supply for pharmaceutical intermediates.
Novel Rh-catalyzed Zolpidem synthesis offers high purity and reduced toxic waste. Ideal for scalable pharmaceutical intermediate manufacturing and supply chain optimization.
Patent CN116354930A reveals a novel Pd/Cu catalyzed route for synthesizing chiral tetrahydroquinolines from amino acids, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN106518663B reveals metal-free synthesis for alpha-acyloxy ketones. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.